my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions more
Angiotech Pharmaceuticals, Inc. and partner Athersys, Inc. announced updated results from its phase I clinical trial of MultiStem(R), its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. The update more
Sirius Genomics announced that Kamran Alam has been appointed Senior Director of Business Development. Mr. Alam has over 12 years experience in the biotech and medical device industry, during which time he has worked in several therapeutic areas in the roles of Business Development and Finance. Pri more
BioSyntech, Inc. announced that it has appointed Ms. Jeanne Bertonis, MBA, M.Sc., to the role of Chief Executive Officer. The Company previously announced that Ms. Bertonis was retained by BioSyntech as a consultant to assist the Company with its research and development, regulatory, strategic plann more
Angiotech Pharmaceuticals, Inc. (ANP) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the Angiotech Pharmaceuticals, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on more
Ceragenix Pharmaceuticals, Inc. (CGXP) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the Ceragenix Pharmaceuticals, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information o more
Futuremed Health Care Products L.P. (Futuremed) is a privately-held medical devices company. It is engaged in the development, manufacture and distribution of innovative healthcare products. The company offers consumable medical supplies, specialized furniture and equipment to the nursing home marke more
Search Search GO About Us Corporate Profile Company History Management Team Intellectual Property Products Product Overview Quill™ SRS 5FU - CVC Interventional Biopsy Ophthalmic Surgical Angiotech Partner Solutions Private Label Healthcare Professionals About... Investors Investor Overview Corporate more
> HOME > CONTACT CORPORATE Profile Leadership In the News Careers RESEARCH Technology Market Indications Publications PRODUCT DEVELOPMENT Development Status Davunetide intranasal Davunetide intravenous Pre-clinical Partnering INVESTOR RELATIONS Leadership Executive Team Gordon C. McCauley Presid more
ANGIOTECH PHARMACEUTICALS ANNOUNCES CONFERENCE CALL AND WEBCAST Second Quarter 2010 Financial Results Vancouver, BC, June 24, 2010 – Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) will host a conference call discussing its financial results for the second quarter e more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
